Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 5/20 | 0.35 |
| ▸ | REN | P00797 | 1/20 | 0.35 |
| ▸ | CTSD | P07339 | 4/20 | 0.35 |
| ▸ | CTSE | P14091 | 4/20 | 0.35 |
| ▸ | STAT3 | P40763 | 7/20 | 0.34 |
| ▸ | BACE1 | P56817 | 2/20 | 0.34 |
| ▸ | PREP | P48147 | 1/20 | 0.33 |
| ▸ | FAP | Q12884 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | PEPD | P12955 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27317143 | 0.76 | CTSD (0.38) | ACERENCTSDCTSESTAT3 | |
| SCHEMBL27404606 | 0.74 | CTSD (0.38) | ACERENCTSDCTSESTAT3 | |
| SCHEMBL27404602 | 0.73 | CTSD (0.41) | ACERENCTSDCTSESTAT3 | |
| SCHEMBL27317324 | 0.73 | CTSD (0.41) | ACERENCTSDCTSESTAT3 | |
| SCHEMBL27410828 | 0.71 | CTSD (0.39) | ACERENCTSDCTSESTAT3 | |
| SCHEMBL17117574 | 0.69 | PREP (0.46) | ACERENPREPFAPLMNA | |
| SCHEMBL30844309 | 0.69 | GRB2 (0.54) | CTSDCTSESTAT3BACE1PREP | |
| SCHEMBL30721557 | 0.69 | ACE (0.42) | ACERENCTSDCTSESTAT3 | |
| SCHEMBL12766400 | 0.68 | ACE (0.49) | ACERENPREPFAPLMNA | |
| SCHEMBL30563282 | 0.68 | GRB2 (0.40) | ACECTSDCTSESTAT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240209028-A1 | CNP COMPOUNDS | NOVO NORDISK A/S (DK) | 2024-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240209028-A1 | CNP COMPOUNDS | NPPA, NPR1, NPR3 | ACE 475/4885REN 138/4885CTSD 876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.